Novavax (NVAX) Tops Q4 EPS by 9c
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $8.89 +3.86%
Revenue Growth %: -78.2%
Financial Fact:
Interest expense: -3.51M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: -78.2%
Financial Fact:
Interest expense: -3.51M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q4 EPS of ($0.51), $0.09 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $88.31 million versus the consensus estimate of $102.74 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oman Warned European Allies Ship Fees Likely Needed For Hormuz - Bloomberg
- Wendy's (WEN) call put ratio 3.5 calls to 1 put with a focus on 2800 contracts of July 9 calls
- UAE Says Situation Currently Safe After Potential Threat Alert
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
